Cardiovascular disease in CKD in 2014: New insights into cardiovascular risk factors and outcomes

Nature Reviews Nephrology

Volumn 11, Issue 2, 2015, Pages 70-72

  Sarafidis, Pantelis A ^a   Bakris, George L ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; FIBROBLAST GROWTH FACTOR 23; LISINOPRIL; SODIUM PHOSPHATE COTRANSPORTER 2A;

ADRENERGIC SYSTEM; ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; END STAGE RENAL DISEASE; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLEEP DISORDERED BREATHING; SODIUM RESTRICTION; SUDDEN CARDIAC DEATH; CARDIOVASCULAR DISEASES; COMPLICATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

CARDIOVASCULAR DISEASES; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84923190750     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2014.242     Document Type: Review

References (10)

1. US Renal Data System. 2013 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. usrds.org [online], http://www.usrds.org/atlas.aspx (2013).
2. Sarafidis, P. A. et al. Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients. Am. J. Nephrol. 40, 242-250 (2014).
3. Sivalingam, M., Chakravorty, I., Mouatt, S. & Farrington, K. Obstructive sleep apnea in incremental hemodialysis: determinants, consequences, and impact on survival. Hemodial. Int. 17, 230-239 (2013).
4. Torino, C. et al. Snoring amplifies the risk of heart failure and mortality in dialysis patients. Am. J. Nephrol. 39, 536-542 (2014).
5. Agarwal, R. et al. Assessment and management of hypertension in patients on dialysis. J. Am. Soc. Nephrol. 25, 1630-1646 (2014).
6. Agarwal, R., Sinha, A. D., Pappas, M. K., Abraham, T. N. & Tegegne, G. G. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol. Dial. Transplant. 29, 672-681 (2014).
7. Zoccali, C. & Mallamaci, F. Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial. Nephrol. Dial. Transplant. 29, 483-485 (2014).
8. Gorostidi, M. et al. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: a 5, 693-patient cross-sectional analysis from Spain. Am. J. Kidney Dis. 62, 285-294 (2013).
9. Minutolo, R. et al. Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. Am. J. Kidney Dis. 64, 744-752 (2014).
10. de Seigneux, S. et al. Proteinuria increases plasma phosphate by altering its tubular handling. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2014010104.